A pilot study of high-throughput, sequence-based mutational profiling of primary human acute myeloid leukemia cell genomes. - Wikidata - wikimedia - TriplyDB

A pilot study of high-throughput, sequence-based mutational profiling of primary human acute myeloid leukemia cell genomes.

A pilot study of high-throughput, sequence-based mutational profiling of primary human acute myeloid leukemia cell genomes.

http://www.wikidata.org/entity/Q33716570

about

Anticipating the 1,000 dollar genome Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies Aspects of coverage in medical DNA sequencing Utilizing the molecular gateway: the path to personalized cancer management.PolyScan: an automatic indel and SNP detection approach to the analysis of human resequencing data.Reduced PU.1 expression causes myeloid progenitor expansion and increased leukemia penetrance in mice expressing PML-RARalpha.PU.1 and Haematopoietic Cell Fate: Dosage Matters Detection of minimal residual disease in NPM1-mutated acute myeloid leukemia by next-generation sequencing.A Drosophila model of multiple endocrine neoplasia type 2.Clinical applications of next generation sequencing in cancer: from panels, to exomes, to genomes.Effects of the leukemia-associated AML1-ETO protein on hematopoietic stem and progenitor cells.Mutational profiling in the human genome.Distinct patterns of mutations occurring in de novo AML versus AML arising in the setting of severe congenital neutropenia.Gatekeeper pathways and cellular background in the pathogenesis and therapy of AML.Resequencing analysis of the candidate tyrosine kinase and RAS pathway gene families in multiple myeloma.Genome-scale definition of the transcriptional programme associated with compromised PU.1 activity in acute myeloid leukaemia.High-throughput mutational analysis of the human cancer genome.Pharmacogenetics of alkylator-associated acute myeloid leukemia.Somatic mutations and germline sequence variants in the expressed tyrosine kinase genes of patients with de novo acute myeloid leukemia.A decade of genome-wide gene expression profiling in acute myeloid leukemia: flashback and prospects.A comparison of two methods for screening CEBPA mutations in patients with acute myeloid leukemia Expression profiling of murine acute promyelocytic leukemia cells reveals multiple model-dependent progression signatures.An integrated genomic approach to the assessment and treatment of acute myeloid leukemia.Prognostic implications of genetic aberrations in acute myelogenous leukemia with normal cytogenetics.A role for BMP-induced homeobox gene MIXL1 in acute myelogenous leukemia and identification of type I BMP receptor as a potential target for therapy.Peptide microarray profiling identifies phospholipase C gamma 1 (PLC-γ1) as a potential target for t(8;21) AML.Mutations of the PU.1 Ets domain are specifically associated with murine radiation-induced, but not human therapy-related, acute myeloid leukaemia.Ultrasensitive detection of acute myeloid leukemia minimal residual disease using single molecule molecular inversion probes.The transcriptomic landscape and directed chemical interrogation of MLL-rearranged acute myeloid leukemias.

P2860

Q21184143-85B8BCCF-3AB9-45A7-874A-8FA0FE5E8BC1 Q24648438-6FA8F38C-03AC-4E51-B62D-89D4BDBC8916 Q24653310-D9D54566-2D6C-40C6-8752-33BD6368FEF4 Q30371443-FF7C502A-DCB6-4E4A-8F9D-18334C3C290E Q31108463-2A1C8FD4-7DB6-47DF-A841-A7BCF922476F Q33920326-10DA6011-EF90-4DD3-862B-E449158C1C97 Q34028171-3D98CAC1-6190-400C-9687-627BF92656C5 Q34364350-7CE65B17-ABB1-4803-A13B-89BE7BFA404C Q34589821-9A283115-6EC6-423A-AFC0-214D161097D0 Q35749677-662EE6E1-A341-4BDF-9B70-FC35DFAFD5BA Q35779705-0DA33E02-E0FE-47BE-AE10-4C89A36AEDEB Q35875106-4437CCDE-E9F6-42DE-9F01-185442696BF4 Q35989473-54322927-6497-4661-B766-D091392F5F4D Q36233848-67719792-215F-4692-BB0F-037AB649A043 Q36234936-681BF872-6DAC-48FA-A8BC-39FBF8D4FEC7 Q36442509-BC0118A4-D631-40B6-9B1A-17EC07ED5A14 Q36497083-664F4006-216B-4956-9A55-B18CC5453E6B Q36555916-2C0E9000-1DB3-4EF1-B1FF-E899CFBE6E79 Q36591394-F44FF37F-4269-43AA-AA4D-C3ABB380D213 Q37041909-0B9131F0-7205-4142-83E5-96B259DDB34B Q37261866-C5866216-46E6-4C98-BD2F-6C3FF990D918 Q37683754-58579A23-9950-40C1-A5EE-56F6136D336C Q37855227-A2536C65-BF23-4652-A481-78D3AAC6F0D0 Q37954583-A5E663CA-7767-4DBD-8F68-942ACBF1AD57 Q38924940-BE815C14-2B81-410A-A50B-AFC0D9929C75 Q41815540-035D781D-14D8-4151-8B73-0CCB8C24447B Q42801824-1C3A815D-7E94-4687-B5D0-6005AC5FCC8E Q47109503-02F87149-4FD4-4AEF-B821-D695BFE393C7 Q48151269-D4DDB2B9-5EA7-4924-9229-D829BA5B0B73

P2860

A pilot study of high-throughput, sequence-based mutational profiling of primary human acute myeloid leukemia cell genomes.

http://www.wikidata.org/entity/Q33716570

description

2003 nî lūn-bûn

@nan

2003 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

A pilot study of high-throughp ...... myeloid leukemia cell genomes.

@ast

A pilot study of high-throughp ...... myeloid leukemia cell genomes.

@en

type

label

A pilot study of high-throughp ...... myeloid leukemia cell genomes.

@ast

A pilot study of high-throughp ...... myeloid leukemia cell genomes.

@en

prefLabel

A pilot study of high-throughp ...... myeloid leukemia cell genomes.

@ast

A pilot study of high-throughp ...... myeloid leukemia cell genomes.

@en

P1433

Q33716570-0D22AD25-213B-451E-B113-884E73E240DC

P1476

Q33716570-3FCEE08D-DA8E-4481-9F84-A13886147F49

P2093

Q33716570-279D98F7-39B0-4948-A5F2-45DCA4A0FDF7

Q33716570-2FD6464E-DE8A-4E53-86B2-66F6EA6EB532

Q33716570-2FD92D88-656D-4B25-8950-23682FB9A74B

Q33716570-309FC44A-3479-44A0-BBF2-B9BBDF677814

Q33716570-3B3CC15F-1819-4872-AE01-9FB939BECE28

Q33716570-413B9C38-B2FF-4F31-A075-20F6A4B8C6B1

Q33716570-446C39EE-F637-4C0D-8B1F-968F9504471D

Q33716570-48BC8BAF-A4C2-4EC8-881F-C936DB93AC95

Q33716570-6DB1495C-3226-4B99-BE94-A9D8D9423A3C

Q33716570-87B3EDEF-C5F2-4B70-AF54-4AC580A9F4BB

P2860

Q33716570-16F7910C-90F9-40D5-9377-05178780F062

Q33716570-1F308EE2-7B3C-4EDC-891E-A7376C65A895

Q33716570-1F863E3E-BB40-4EF7-B2D0-5934DA09311A

Q33716570-3903BF77-B92B-4E3C-872A-F8324462D225

Q33716570-3B24EEEC-A22A-4BB1-AB3A-2C6651F2AD3D

Q33716570-3D64F08E-CD64-4FA3-BE00-D1092CF6D640

Q33716570-452D1D8E-CBDD-4511-A282-9C2745475472

Q33716570-48777868-433E-495A-B4B2-F44B3AEF5D63

Q33716570-586D7956-04E1-4068-8DD6-5A0CB13853DC

Q33716570-63709F3C-467B-4618-81A5-60E2AA484275

P304

Q33716570-C360C078-2248-4BAF-B71E-5228D787FF87

P31

Q33716570-9C05BC7D-6125-44D4-98C0-DB8567F00C5C

P356

Q33716570-630E9F85-DE32-4CC2-B860-16CE97F46BB2

P407

Q33716570-E8C7B209-AC2A-47B0-BAF4-446577CF81B5

P433

Q33716570-213712E3-120A-402B-8982-6B617036931C

P478

Q33716570-D457E1B2-07B4-4FBD-8B70-F2E156A45CA6

P50

Q33716570-018B37B6-FB54-483D-AA51-C9A230786ED2

Q33716570-619E26FB-F2CB-447C-88E9-19EFD1CB6616

Q33716570-BE248690-82DC-40B5-93F5-770CC0E6A2C9

P577

Q33716570-42F0D254-E0A6-468A-960F-2C711D432D6E

P5875

Q33716570-4F5E83C8-DB4A-49E4-A0B2-689822BFE417

P698

Q33716570-87A36E3D-3422-4ABF-83AA-93EEED9CCE10

P921

Q33716570-ADA2C0A3-6610-4422-B980-A83A7EA55F93

P932

Q33716570-151FB9E2-903C-4512-A7A2-474B65B7B568

P356

PNAS.2335924100

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

A pilot study of high-throughp ...... myeloid leukemia cell genomes

@en

P2093

Clara D Bloomfield

http://www.w3.org/2001/XMLSchema#string

Daniel C Link

http://www.w3.org/2001/XMLSchema#string

Elaine R Mardis

http://www.w3.org/2001/XMLSchema#string

Hanna Khoury

http://www.w3.org/2001/XMLSchema#string

Howard McLeod

http://www.w3.org/2001/XMLSchema#string

Hui Sun

http://www.w3.org/2001/XMLSchema#string

James W Vardiman

http://www.w3.org/2001/XMLSchema#string

John F DiPersio

http://www.w3.org/2001/XMLSchema#string

Kathryn Trinkaus

http://www.w3.org/2001/XMLSchema#string

Mark Watson

http://www.w3.org/2001/XMLSchema#string

P2860

Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-alpha (C/EBPalpha), in acute myeloid leukemia

Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies.

Consed: a graphical tool for sequence finishing

Mutational analysis of the tyrosine kinome in colorectal cancers

PolyPhred: automating the detection and genotyping of single nucleotide substitutions using fluorescence-based resequencing

Mutations in ras proto-oncogenes are associated with lower mdr1 gene expression in adult acute myeloid leukaemia.

Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia.

In vitro analyses of known and novel RUNX1/AML1 mutations in dominant familial platelet disorder with predisposition to acute myelogenous leukemia: implications for mechanisms of pathogenesis.

A novel inherited mutation of the transcription factor RUNX1 causes thrombocytopenia and may predispose to acute myeloid leukaemia.

PML/RARalpha and FLT3-ITD induce an APL-like disease in a mouse model

P304

14275-14280

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.2335924100

http://www.w3.org/2001/XMLSchema#string

P407

P433

24

http://www.w3.org/2001/XMLSchema#string

P478

100

http://www.w3.org/2001/XMLSchema#string

P50

Timothy A. Graubert

Jeffrey Milbrandt

Michael H Tomasson

P577

2003-11-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

9012228

http://www.w3.org/2001/XMLSchema#string

P698

14614138

http://www.w3.org/2001/XMLSchema#string

P921

P932

283582

http://www.w3.org/2001/XMLSchema#string